Published in J Urban Health on July 01, 2010
HIV prevalence and related risk behaviours among prisoners in Iran: results of the national biobehavioural survey, 2009. Sex Transm Infect (2013) 0.96
HIV trend among Iranian prisoners in 1990s and 2000s; analysis of aggregated data from HIV sentinel sero-surveys. Harm Reduct J (2013) 0.80
Vaccinations in prisons: A shot in the arm for community health. Hum Vaccin Immunother (2015) 0.77
Outcome assessment of a triangular clinic as a harm reduction intervention in Rajaee-Shahr Prison, Iran. Harm Reduct J (2013) 0.76
Pharmacotherapy for opioid dependence in jails and prisons: research review update and future directions. Subst Abuse Rehabil (2016) 0.75
Cytogenetic risks and possible adverse health effects by narcotic substances dependent. Int J Prev Med (2012) 0.75
Drug Use and HIV Infection Status of Detainees in Re-Education through Labour Camps in Guangxi Province, China. Int J Environ Res Public Health (2015) 0.75
Outbreak of HIV infection in a Scottish prison. BMJ (1995) 3.82
Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health (2004) 3.32
Sexual behaviour in Scottish prisons. BMJ (1991) 2.68
HIV prevalence and risk behaviours for HIV transmission in South Australian prisons. AIDS (1991) 2.30
Interventions to reduce HIV transmission related to injecting drug use in prison. Lancet Infect Dis (2009) 2.18
Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction (1993) 2.01
History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin. Int J Epidemiol (1997) 1.90
HIV/AIDS harm reduction in Iran. Lancet (2006) 1.72
High prevalence of HIV infection associated with incarceration among community-based injecting drug users in Tehran, Iran. J Acquir Immune Defic Syndr (2006) 1.71
Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--Iran. World J Gastroenterol (2005) 1.67
HIV infection and risk factors among Bangkok prisoners, Thailand: a prospective cohort study. BMC Infect Dis (2003) 1.56
Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study. BMJ (2003) 1.56
Preventing HIV transmission among Iranian prisoners: initial support for providing education on the benefits of harm reduction practices. Harm Reduct J (2008) 1.50
Prevalence of and factors associated with HIV-1 infection among drug users visiting treatment centers in Tehran, Iran. AIDS (2005) 1.49
HIV transmission in a prison system in an Australian State. Med J Aust (1999) 1.35
Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran. Int J Drug Policy (2010) 1.23
Prevalence and risk behaviours for HIV infection among inmates of a provincial prison in Quebec City. AIDS (1996) 1.13
HIV seroconversion among injection drug users in detention, Tehran, Iran. AIDS (2009) 1.06
HIV epidemiology and risk behavior promoting HIV transmission in Austrian prisons. Eur J Epidemiol (1994) 1.05
A qualitative inquiry into methadone maintenance treatment for opioid-dependent prisoners in Tehran, Iran. Int J Drug Policy (2009) 0.96
Sexually transmitted diseases and incarceration. Curr Opin Infect Dis (2009) 0.95
Substance misuse among prisoners in England and Wales. Int Rev Psychiatry (2004) 0.93
High rates of drug use, but low rates of HIV risk behaviours among injecting drug users during incarceration in Dutch prisons. Addiction (1998) 0.83
Multiperson use of syringes among injection drug users in a needle exchange program: a gene-based molecular epidemiologic analysis. J Acquir Immune Defic Syndr (2006) 0.82
Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA (2010) 5.04
Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis (2002) 1.73
Sexual behavior and awareness of Chinese university students in transition with implied risk of sexually transmitted diseases and HIV infection: a cross-sectional study. BMC Public Health (2006) 1.72
High prevalence of HIV infection associated with incarceration among community-based injecting drug users in Tehran, Iran. J Acquir Immune Defic Syndr (2006) 1.71
Early initiation of sexual activity: a risk factor for sexually transmitted diseases, HIV infection, and unwanted pregnancy among university students in China. BMC Public Health (2009) 1.68
Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran. Int J Drug Policy (2007) 1.57
Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial. Hypertension (2008) 1.54
Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran, Iran: a cross-sectional study. Harm Reduct J (2005) 1.53
Acute hemodynamic effects of adaptive servo-ventilation in patients with heart failure. Circ J (2013) 1.53
Prevalence of and factors associated with HIV-1 infection among drug users visiting treatment centers in Tehran, Iran. AIDS (2005) 1.49
Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association. Gastric Cancer (2013) 1.49
Role of diabetes and obesity in outcomes of the candesartan antihypertensive survival evaluation in Japan (CASE-J) trial. Hypertens Res (2010) 1.47
Demographic and behavioral characteristics of male sexually transmitted disease patients in Japan: a nationwide case-control study. Sex Transm Dis (2008) 1.45
Effects of cardiac complications on cardiovascular events in Japanese high-risk hypertensive patients: subanalysis of the CASE-J trial. Circ J (2009) 1.40
Substance use and sexual behaviours of Japanese men who have sex with men: a nationwide internet survey conducted in Japan. BMC Public Health (2006) 1.32
Progression-free survival as a surrogate for overall survival in advanced/recurrent gastric cancer trials: a meta-analysis. J Natl Cancer Inst (2013) 1.28
Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis. Eur J Cancer (2013) 1.24
Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran. Int J Drug Policy (2010) 1.13
CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls. Int J Cancer (2003) 1.13
Needle and syringe sharing practices among injecting drug users in Tehran: a comparison of two neighborhoods, one with and one without a needle and syringe program. AIDS Behav (2008) 1.10
Sexual behaviors and their correlates among young people in Mauritius: a cross-sectional study. BMC Int Health Hum Rights (2007) 1.08
Left paraduodenal hernia successfully treated with laparoscopic surgery: a case report. Case Rep Gastroenterol (2007) 1.07
Pooled analysis of the CYP1A1 exon 7 polymorphism and lung cancer (United States). Cancer Causes Control (2003) 1.04
The optimal target blood pressure for antihypertensive treatment in Japanese elderly patients with high-risk hypertension: a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial. Hypertens Res (2008) 1.03
Unintended pregnancy and its risk factors among university students in eastern China. Contraception (2008) 1.01
Phase II trial of paclitaxel and cisplatin as neoadjuvant chemotherapy for locally advanced gastric cancer. Cancer Chemother Pharmacol (2013) 1.01
Prospective phase II study of FOLFIRI for mCRC in Japan, including the analysis of UGT1A1 28/6 polymorphisms. Jpn J Clin Oncol (2011) 1.00
Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trials. Cancer Immunol Immunother (2005) 0.96
HIV prevalence and related risk behaviours among prisoners in Iran: results of the national biobehavioural survey, 2009. Sex Transm Infect (2013) 0.96
A qualitative inquiry into methadone maintenance treatment for opioid-dependent prisoners in Tehran, Iran. Int J Drug Policy (2009) 0.96
Behavioral and psychosocial predictors of condom use among university students in Eastern China. AIDS Care (2009) 0.94
Changing patterns of HIV epidemic in 30 years in East Asia. Curr HIV/AIDS Rep (2014) 0.93
Regional Differences in Prevalence of Macrolide Resistance among Pediatric Mycoplasma pneumoniae Infections in Hokkaido, Japan. Jpn J Infect Dis (2015) 0.93
A new prognostic classification for overall survival in Asian patients with previously untreated metastatic renal cell carcinoma. Cancer Sci (2012) 0.93
HIV/AIDS surveillance in Japan, 1984-2000. J Acquir Immune Defic Syndr (2003) 0.91
Multicenter phase II study of second-line cetuximab plus folinic acid/5-fluorouracil/irinotecan (FOLFIRI) in KRAS wild-type metastatic colorectal cancer: the FLIER study. Anticancer Res (2014) 0.90
Relationship between the achieved blood pressure and the incidence of cardiovascular events in Japanese hypertensive patients with complications: a sub-analysis of the CASE-J trial. Hypertens Res (2009) 0.90
Randomized controlled trial on the skin toxicity of panitumumab in Japanese patients with metastatic colorectal cancer: HGCSG1001 study; J-STEPP. Future Oncol (2015) 0.90
Association of metabolic gene polymorphisms with tobacco consumption in healthy controls. Int J Cancer (2004) 0.89
The domain structure of the EORTC QLQ-STO22 supported by Japanese validation data. Psychooncology (2008) 0.88
The characterisation of sexual behaviour in Chinese male university students who have sex with other men: a cross-sectional study. BMC Public Health (2008) 0.88
Is pulse pressure a predictor of new-onset diabetes in high-risk hypertensive patients?: a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial. Diabetes Care (2010) 0.88
Potential for sexual transmission of HIV infection from male injecting-drug users who have sex with men in Tehran, Iran. Sex Transm Dis (2010) 0.87
Is Memorial Sloan-Kettering Cancer Center risk classification appropriate for Japanese patients with metastatic renal cell carcinoma in the cytokine era? Urol Oncol (2011) 0.86
UGT1A1*6, 1A7*3, and 1A9*22 genotypes predict severe neutropenia in FOLFIRI-treated metastatic colorectal cancer in two prospective studies in Japan. Cancer Sci (2013) 0.86
HIV-related risk behaviours and the correlates among rickshaw pullers of Kamrangirchar, Dhaka, Bangladesh: a cross-sectional study using probability sampling. BMC Public Health (2009) 0.86
The intent and practice of condom use among HIV-positive men who have sex with men in Japan. AIDS Patient Care STDS (2006) 0.85
HIV prevention for Asian and Pacific Islander men who have sex with men: identifying needs for the Asia Pacific region. AIDS Educ Prev (2004) 0.85
Long-term renal function outcomes in bladder cancer after radical cystectomy. Urol J (2013) 0.85
Relative increase in lymphocytes from as early as 1 month predicts improved response to dasatinib in chronic-phase chronic myelogenous leukemia. Int J Hematol (2013) 0.85
Prevalence and correlates of sexual behaviors among karen villagers in northern Thailand. AIDS Behav (2007) 0.84
Assessing clinical benefit response in the treatment of gastric malignant ascites with non-measurable lesions: a multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced/recurrent gastric cancer. Gastric Cancer (2011) 0.84
Demographic and behavioral characteristics of non-sex worker females attending sexually transmitted disease clinics in Japan: a nationwide case-control study. BMC Public Health (2010) 0.83
HIV antibody testing and its correlates among heterosexual attendees of sexually transmitted disease clinics in China. BMC Public Health (2013) 0.83
Longitudinal comparison of quality of life after real-time tumor-tracking intensity-modulated radiation therapy and radical prostatectomy in patients with localized prostate cancer. J Radiat Res (2013) 0.83
Numbers of people with HIV/AIDS reported and not reported to surveillance in Japan. J Epidemiol (2004) 0.82
Initial safety report on the tolerability of modified FOLFOX6 as adjuvant therapy in patients with curatively resected stage II or III colon cancer (JFMC41-1001-C2: JOIN trial). Cancer Chemother Pharmacol (2015) 0.81
Pharmacokinetic study of weekly administration dose of paclitaxel in patients with advanced or recurrent gastric cancer in Japan. Gastric Cancer (2007) 0.81
A feasibility study of sequential paclitaxel and S-1 (PTX/S-1) chemotherapy as postoperative adjuvant chemotherapy for advanced gastric cancer. Gastric Cancer (2006) 0.81
Is there diversity among UGT1A1 polymorphism in Japan? World J Gastrointest Oncol (2012) 0.80
Prospective phase II trial of second-line FOLFIRI in patients with advanced colorectal cancer including analysis of UGT1A1 polymorphisms: FLIGHT 2 study. Anticancer Res (2014) 0.80
A phase I study of palliative chemoradiation therapy with paclitaxel and cisplatin for local symptoms due to an unresectable primary advanced or locally recurrent gastric adenocarcinoma. Cancer Chemother Pharmacol (2009) 0.80
Decreased serum brain-derived neurotrophic factor levels are correlated with exercise intolerance in patients with heart failure. Int J Cardiol (2013) 0.80
FOLFIRI plus bevacizumab 5 mg/kg versus 10 mg/kg as second-line therapy in patients with metastatic colorectal cancer who have failed first-line bevacizumab plus oxaliplatin-based therapy: a randomized phase III study (EAGLE Study). Jpn J Clin Oncol (2011) 0.80
Vulnerability to HIV infection among female drug users in Kathmandu Valley, Nepal: a cross-sectional study. BMC Public Health (2013) 0.79
Diamine oxidase as a marker of intestinal mucosal injury and the effect of soluble dietary fiber on gastrointestinal tract toxicity after intravenous 5-fluorouracil treatment in rats. Med Mol Morphol (2013) 0.79
Differences in UGT1A1, UGT1A7, and UGT1A9 polymorphisms between Uzbek and Japanese populations. Mol Diagn Ther (2014) 0.78
Optimal predictive value of preoperative serum carcinoembryonic antigen for surgical outcomes in stage I non-small cell lung cancer: differences according to histology and smoking status. J Surg Oncol (2012) 0.78
Methamphetamine use and correlates in two villages of the highland ethnic Karen minority in northern Thailand: a cross sectional study. BMC Int Health Hum Rights (2009) 0.78
Matched pair analysis to examine the effects of a planned preoperative exercise program in early gastric cancer patients with metabolic syndrome to reduce operative risk: the Adjuvant Exercise for General Elective Surgery (AEGES) study group. Ann Surg Oncol (2014) 0.78
Temperament and character profiles of Japanese university students with depressive episodes and ideas of suicide or self-harm: a PHQ-9 screening study. Compr Psychiatry (2013) 0.77
Phase II study on hepatic arterial infusion chemotherapy using percutaneous catheter placement techniques for liver metastases from colorectal cancer (JFMC28 study). Asia Pac J Clin Oncol (2015) 0.77